Clinical Trial Update: 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma [Phase 2]

View source ↗

Summary

This document notes the withdrawal of a Phase 2 clinical trial evaluating 18F-FLT PET imaging to monitor treatment response in non-small cell lung cancer and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Thymoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Non-Small-Cell Lung, Thymus Neoplasms | Phase 2 | Status: WITHDRAWN